Almira Chabi

About

Almira Chabi serves as the Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International. Based in the United States, her research primarily focuses on the application of deep learning in ophthalmology and the clinical evaluation of treatments for glaucoma and ocular hypertension. Recent publications include studies on multimodal deep learning techniques for predicting visual fields and a randomized trial comparing different dosing regimens of Omidenepag Isopropyl.